Name (Synonyms) | Correlation | |
---|---|---|
drug352 | Biological test Wiki | 1.00 |
drug1935 | Proxalutamide Wiki | 1.00 |
drug799 | Dutasteride Wiki | 1.00 |
drug1270 | Ivermectin Wiki | 0.24 |
drug262 | Azithromycin Wiki | 0.17 |
Name (Synonyms) | Correlation | |
---|---|---|
D006965 | Hyperplasia NIH | 1.00 |
D000505 | Alopecia NIH | 0.71 |
D045169 | Severe Acute Respiratory Syndrome NIH | 0.05 |
D018352 | Coronavirus Infections NIH | 0.04 |
Name (Synonyms) | Correlation | |
---|---|---|
HP:0008711 | Benign prostatic hyperplasia HPO | 1.00 |
HP:0002293 | Alopecia of scalp HPO | 0.71 |
There is one clinical trial.
This study is intended to explore the possible protective role of anti-androgens in SARS-CoV-2 infection
Description: Percentage of subjects hospitalized due to COVID-19
Measure: COVID-19 hospitalization Time: 30 daysDescription: COVID Ordinal Scale defined as: Death Hospitalized on invasive mechanical ventilation or ECMO ( extracorporeal membrane oxygenation) Hospitalized on non-invasive ventilation or high flow nasal cannula Hospitalized on supplemental oxygen Hospitalized not on supplemental oxygen Not hospitalized with limitation in activity (continued symptoms) Not hospitalized without limitation in activity (no symptoms)
Measure: COVID-19 Ordinal Outcomes Scale Time: 30 daysDescription: Symptoms severity of COVID-19 using Brescia-COVID Respiratory Severity Scale (BCRSS)/Algorithm
Measure: Symptoms severity of COVID-19 Time: 30 days